+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Diabetes Management Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 255 Pages
  • January 2024
  • Region: Global
  • Infinium Global Research
  • ID: 5933653
The report on the global digital diabetes management market provides qualitative and quantitative analysis for the period from 2021-2030. The global digital diabetes management market was valued at USD 11.84 billion in 2022 and is expected to reach USD 24.43 billion in 2030, with a CAGR of 8.22% during the forecast period 2023-2030. The study on digital diabetes management market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on digital diabetes management market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global digital diabetes management market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global digital diabetes management market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The rising aging population and the increasing prevalence of diabetes are expected to drive market growth.
  • Growing emphasis on patient-centric care and the need for active patient involvement in managing diabetes are fueling the demand for digital diabetes management solutions.

2) Restraints

  • Limited access to advanced digital technologies and high initial implementation costs hinder the widespread adoption which can limit the market.

3) Opportunities

  • Advancements in wearable technology and artificial intelligence for personalized diabetes management solutions create lucrative opportunities for the market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global digital diabetes management market is segmented on the basis of device type, product, and end user.

The Global Digital Diabetes Management Market by Device Type

  • Handheld Devices
  • Wearable Devices

The Global Digital Diabetes Management Market by Product

  • Continuous Blood Glucose Monitoring Systems
  • Smart Glucose Meter
  • Smart Insulin Pumps
  • Smart Insulin Pens
  • Others

The Global Digital Diabetes Management Market by End User

  • Hospital
  • Home settings
  • Diagnostic center

Company Profiles

The companies covered in the report include

  • Medtronic
  • Abbott Laboratories
  • Insulet Corporation
  • Tidepool
  • Azumio Inc
  • Glooko, Inc.
  • Dexcom, Inc.
  • AgaMatrix
  • DarioHealth Corp.
  • F. Hoffmann-La Roche Ltd

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the digital diabetes management market.
2. Complete coverage of all the segments in the digital diabetes management market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global digital diabetes management market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Digital Diabetes Management Market Highlights
2.2. Digital Diabetes Management Market Projection
2.3. Digital Diabetes Management Market Regional Highlights
Chapter 3. Global Digital Diabetes Management Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Device Type
3.4.2. Growth Matrix Analysis by Product
3.4.3. Growth Matrix Analysis by End User
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Digital Diabetes Management Market
Chapter 4. Digital Diabetes Management Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Digital Diabetes Management Market
5.2. Companies Profiles
5.2.1. Medtronic
5.2.2. Abbott Laboratories
5.2.3. Insulet Corporation
5.2.4. Tidepool
5.2.5. Azumio Inc
5.2.6. Glooko, Inc.
5.2.7. Dexcom, Inc.
5.2.8. AgaMatrix
5.2.9. DarioHealth Corp.
5.2.10. F. Hoffmann-La Roche Ltd
Chapter 6. Global Digital Diabetes Management Market by Device Type
6.1. Handheld Devices
6.2. Wearable Devices
Chapter 7. Global Digital Diabetes Management Market by Product
7.1. Continuous Blood Glucose Monitoring Systems
7.2. Smart Glucose Meter
7.3. Smart Insulin Pumps
7.4. Smart Insulin Pens
7.5. Others
Chapter 8. Global Digital Diabetes Management Market by End User
8.1. Hospital
8.2. Home settings
8.3. Diagnostic center
Chapter 9. Global Digital Diabetes Management Market by Region 2023-2030
9.1. North America
9.1.1. North America Digital Diabetes Management Market by Device Type
9.1.2. North America Digital Diabetes Management Market by Product
9.1.3. North America Digital Diabetes Management Market by End User
9.1.4. North America Digital Diabetes Management Market by Country
9.1.4.1. The U.S. Digital Diabetes Management Market
9.1.4.1.1. The U.S. Digital Diabetes Management Market by Device Type
9.1.4.1.2. The U.S. Digital Diabetes Management Market by Product
9.1.4.1.3. The U.S. Digital Diabetes Management Market by End User
9.1.4.2. Canada Digital Diabetes Management Market
9.1.4.2.1. Canada Digital Diabetes Management Market by Device Type
9.1.4.2.2. Canada Digital Diabetes Management Market by Product
9.1.4.2.3. Canada Digital Diabetes Management Market by End User
9.1.4.3. Mexico Digital Diabetes Management Market
9.1.4.3.1. Mexico Digital Diabetes Management Market by Device Type
9.1.4.3.2. Mexico Digital Diabetes Management Market by Product
9.1.4.3.3. Mexico Digital Diabetes Management Market by End User
9.2. Europe
9.2.1. Europe Digital Diabetes Management Market by Device Type
9.2.2. Europe Digital Diabetes Management Market by Product
9.2.3. Europe Digital Diabetes Management Market by End User
9.2.4. Europe Digital Diabetes Management Market by Country
9.2.4.1. Germany Digital Diabetes Management Market
9.2.4.1.1. Germany Digital Diabetes Management Market by Device Type
9.2.4.1.2. Germany Digital Diabetes Management Market by Product
9.2.4.1.3. Germany Digital Diabetes Management Market by End User
9.2.4.2. United Kingdom Digital Diabetes Management Market
9.2.4.2.1. United Kingdom Digital Diabetes Management Market by Device Type
9.2.4.2.2. United Kingdom Digital Diabetes Management Market by Product
9.2.4.2.3. United Kingdom Digital Diabetes Management Market by End User
9.2.4.3. France Digital Diabetes Management Market
9.2.4.3.1. France Digital Diabetes Management Market by Device Type
9.2.4.3.2. France Digital Diabetes Management Market by Product
9.2.4.3.3. France Digital Diabetes Management Market by End User
9.2.4.4. Italy Digital Diabetes Management Market
9.2.4.4.1. Italy Digital Diabetes Management Market by Device Type
9.2.4.4.2. Italy Digital Diabetes Management Market by Product
9.2.4.4.3. Italy Digital Diabetes Management Market by End User
9.2.4.5. Rest of Europe Digital Diabetes Management Market
9.2.4.5.1. Rest of Europe Digital Diabetes Management Market by Device Type
9.2.4.5.2. Rest of Europe Digital Diabetes Management Market by Product
9.2.4.5.3. Rest of Europe Digital Diabetes Management Market by End User
9.3. Asia Pacific
9.3.1. Asia Pacific Digital Diabetes Management Market by Device Type
9.3.2. Asia Pacific Digital Diabetes Management Market by Product
9.3.3. Asia Pacific Digital Diabetes Management Market by End User
9.3.4. Asia Pacific Digital Diabetes Management Market by Country
9.3.4.1. China Digital Diabetes Management Market
9.3.4.1.1. China Digital Diabetes Management Market by Device Type
9.3.4.1.2. China Digital Diabetes Management Market by Product
9.3.4.1.3. China Digital Diabetes Management Market by End User
9.3.4.2. Japan Digital Diabetes Management Market
9.3.4.2.1. Japan Digital Diabetes Management Market by Device Type
9.3.4.2.2. Japan Digital Diabetes Management Market by Product
9.3.4.2.3. Japan Digital Diabetes Management Market by End User
9.3.4.3. India Digital Diabetes Management Market
9.3.4.3.1. India Digital Diabetes Management Market by Device Type
9.3.4.3.2. India Digital Diabetes Management Market by Product
9.3.4.3.3. India Digital Diabetes Management Market by End User
9.3.4.4. South Korea Digital Diabetes Management Market
9.3.4.4.1. South Korea Digital Diabetes Management Market by Device Type
9.3.4.4.2. South Korea Digital Diabetes Management Market by Product
9.3.4.4.3. South Korea Digital Diabetes Management Market by End User
9.3.4.5. Australia Digital Diabetes Management Market
9.3.4.5.1. Australia Digital Diabetes Management Market by Device Type
9.3.4.5.2. Australia Digital Diabetes Management Market by Product
9.3.4.5.3. Australia Digital Diabetes Management Market by End User
9.3.4.6. Rest of Asia-Pacific Digital Diabetes Management Market
9.3.4.6.1. Rest of Asia-Pacific Digital Diabetes Management Market by Device Type
9.3.4.6.2. Rest of Asia-Pacific Digital Diabetes Management Market by Product
9.3.4.6.3. Rest of Asia-Pacific Digital Diabetes Management Market by End User
9.4. RoW
9.4.1. RoW Digital Diabetes Management Market by Device Type
9.4.2. RoW Digital Diabetes Management Market by Product
9.4.3. RoW Digital Diabetes Management Market by End User
9.4.4. RoW Digital Diabetes Management Market by Sub-region
9.4.4.1. Latin America Digital Diabetes Management Market
9.4.4.1.1. Latin America Digital Diabetes Management Market by Device Type
9.4.4.1.2. Latin America Digital Diabetes Management Market by Product
9.4.4.1.3. Latin America Digital Diabetes Management Market by End User
9.4.4.2. Middle East Digital Diabetes Management Market
9.4.4.2.1. Middle East Digital Diabetes Management Market by Device Type
9.4.4.2.2. Middle East Digital Diabetes Management Market by Product
9.4.4.2.3. Middle East Digital Diabetes Management Market by End User
9.4.4.3. Africa Digital Diabetes Management Market
9.4.4.3.1. Africa Digital Diabetes Management Market by Device Type
9.4.4.3.2. Africa Digital Diabetes Management Market by Product
9.4.4.3.3. Africa Digital Diabetes Management Market by End User

Companies Mentioned

  • Medtronic
  • Abbott Laboratories
  • Insulet Corporation
  • Tidepool
  • Azumio Inc
  • Glooko, Inc.
  • Dexcom, Inc.
  • AgaMatrix
  • DarioHealth Corp.
  • F. Hoffmann-La Roche Ltd